Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Human platelets utilize cycloxygenase-1 to generate dioxolane A3, a neutrophil activating eicosanoid

Hinz, Christine, Aldrovandi, MacEler, Alam, Saydul, Slatter, David, Lauder, Sarah Nicol, Allen-Redpath, Keith, Collins, Peter William, Thomas, Christopher P. and O'Donnell, Valerie Bridget 2016. Human platelets utilize cycloxygenase-1 to generate dioxolane A3, a neutrophil activating eicosanoid. Journal of Biological Chemistry 291 (26) , pp. 13448-13464. 10.1074/jbc.M115.700609

[img]
Preview
PDF - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (3MB) | Preview

Abstract

Eicosanoids are important mediators of fever, pain and inflammation that modulate cell signaling during acute and chronic disease. We show using lipidomics, that thrombin-activated human platelets generate a new type of eicosanoid which both stimulates and primes human neutrophil integrin (Mac-1) expression, in response to fMLP . Detailed characterization supports a dioxolane (DX) structure, 8-hydroxy-9,11-dioxolane eicosatriaenoic acid (dioxolane A3, DXA3). The lipid is generated in ng amounts by platelets from endogenous arachidonate during physiological activation, with inhibition by aspirin in vitro or in vivo, implicating cyclooxygenase-1 (COX). Pharmacological and genetic studies on human/murine platelets revealed that DXA3 formation requires protease-activated receptors (PAR) 1 and 4, cytosolic phospholipase A2 (cPLA2), src tyrosine kinases, p38 MAP kinase, phospholipase C and intracellular calcium. From data generated by purified COX isoforms and chemical oxidation, we propose that DXA3 is generated release of a dioxolane from the active site followed by oxygenation at C8. In summary, a new neutrophil- activating platelet-derived lipid generated by COX-1 is presented, that can activate or prime human neutrophils, suggesting a role in innate immunity and acute inflammation.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Pharmacy
Systems Immunity Research Institute (SIURI)
Subjects: R Medicine > R Medicine (General)
Publisher: American Society for Biochemistry and Molecular Biology
ISSN: 0021-9258
Funders: Wellcome Trust
Date of First Compliant Deposit: 26 April 2016
Date of Acceptance: 22 April 2016
Last Modified: 05 Nov 2019 03:41
URI: http://orca-mwe.cf.ac.uk/id/eprint/89971

Citation Data

Cited 7 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics